REPORTS

Let’s Pullulate and Expand Your Business

Global Non-steroidal Anti-inflammatory Drugs Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Apr 25, 2020  |  154 PAGES  |  REPORT CODE: CMM281612
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The Non-steroidal Anti-inflammatory Drugs is expected to grow from USD XX.0 million in 2018 to XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period. The research provides insights for the global Non-steroidal Anti-inflammatory Drugs market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Non-steroidal Anti-inflammatory Drugs industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Non-steroidal Anti-inflammatory Drugs Market Segmentations:

By Players:

  • Bayer

  • Novacap

  • Abbott

  • Pfizer

  • Geri-Care Pharmaceuticals

  • Perrigo Company

  • Kopran

  • Merck Sharp & Dohme

  • Sun Pharmaceutical Industries

  • Glaxo Smith Kline

  • Reddy Pharmaceuticals

  • Johnson & Johnson

By Types:

  • Aspirin

  • Ibuprofen

  • Naproxen

  • Nabumetone

  • Others

By End-User:

  • Back Pain Treatment

  • Osteoarthritis Treatment

  • Other

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Non-steroidal Anti-inflammatory Drugs Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate of Aspirin from 2014 to 2026

    • 1.3.2 Global Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate of Ibuprofen from 2014 to 2026

    • 1.3.3 Global Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate of Naproxen from 2014 to 2026

    • 1.3.4 Global Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate of Nabumetone from 2014 to 2026

    • 1.3.5 Global Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate of Others from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate of Back Pain Treatment from 2014 to 2026

    • 1.4.2 Global Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate of Osteoarthritis Treatment from 2014 to 2026

    • 1.4.3 Global Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate of Other from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Non-steroidal Anti-inflammatory Drugs Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Non-steroidal Anti-inflammatory Drugs by Major Types

    • 3.4.1 Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate of Aspirin

    • 3.4.2 Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate of Ibuprofen

    • 3.4.3 Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate of Naproxen

    • 3.4.4 Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate of Nabumetone

    • 3.4.5 Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate of Others

4 Segmentation of Non-steroidal Anti-inflammatory Drugs Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Non-steroidal Anti-inflammatory Drugs by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Non-steroidal Anti-inflammatory Drugs in Back Pain Treatment

    • 4.4.2 Market Size and Growth Rate of Non-steroidal Anti-inflammatory Drugs in Osteoarthritis Treatment

    • 4.4.3 Market Size and Growth Rate of Non-steroidal Anti-inflammatory Drugs in Other

5 Market Analysis by Major Regions

  • 5.1 Global Non-steroidal Anti-inflammatory Drugs Production Analysis by Major Regions

  • 5.2 Global Non-steroidal Anti-inflammatory Drugs Consumption Analysis by Major Regions

  • 5.3 Global Non-steroidal Anti-inflammatory Drugs Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Non-steroidal Anti-inflammatory Drugs Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Non-steroidal Anti-inflammatory Drugs Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Production, Import, Consumption and Export Analysis

6 Product Commodity of Non-steroidal Anti-inflammatory Drugs Market in Major Countries

  • 6.1 Top 5 Export Countries in Non-steroidal Anti-inflammatory Drugs market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Non-steroidal Anti-inflammatory Drugs market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Non-steroidal Anti-inflammatory Drugs market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Non-steroidal Anti-inflammatory Drugs market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Non-steroidal Anti-inflammatory Drugs market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Non-steroidal Anti-inflammatory Drugs market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Non-steroidal Anti-inflammatory Drugs Landscape Analysis

  • 7.1 North America Non-steroidal Anti-inflammatory Drugs Landscape Analysis by Major Types

  • 7.2 North America Non-steroidal Anti-inflammatory Drugs Landscape Analysis by Major End-Users

  • 7.3 North America Non-steroidal Anti-inflammatory Drugs Landscape Analysis by Major Countries

    • 7.3.1 United States Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

    • 7.3.2 Canada Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

    • 7.3.3 Mexico Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

8 Europe Non-steroidal Anti-inflammatory Drugs Landscape Analysis

  • 8.1 Europe Non-steroidal Anti-inflammatory Drugs Landscape Analysis by Major Types

  • 8.2 Europe Non-steroidal Anti-inflammatory Drugs Landscape Analysis by Major End-Users

  • 8.3 Europe Non-steroidal Anti-inflammatory Drugs Landscape Analysis by Major Countries

    • 8.3.1 Germany Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

    • 8.3.2 UK Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

    • 8.3.3 France Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

    • 8.3.4 Italy Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

    • 8.3.6 Spain Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

    • 8.3.7 Belgium Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

    • 8.3.8 Poland Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

    • 8.3.9 Russia Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

    • 8.3.10 Turkey Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

9 Asia Pacific Non-steroidal Anti-inflammatory Drugs Landscape Analysis

  • 9.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs Landscape Analysis by Major Types

  • 9.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs Landscape Analysis by Major Countries

    • 9.3.1 China Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

    • 9.3.2 Japan Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

    • 9.3.4 India Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

    • 9.3.6 South Korea Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

10 Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

    • 10.3.2 Brazil Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

    • 10.3.3 Nigeria Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

    • 10.3.4 South Africa Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate 

    • 10.3.5 Argentina Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Bayer

    • 11.1.1 Bayer Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Novacap

    • 11.2.1 Novacap Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Abbott

    • 11.3.1 Abbott Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Pfizer

    • 11.4.1 Pfizer Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Geri-Care Pharmaceuticals

    • 11.5.1 Geri-Care Pharmaceuticals Company Profile and Recent Development

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Perrigo Company

    • 11.6.1 Perrigo Company Company Profile and Recent Development

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Kopran

    • 11.7.1 Kopran Company Profile and Recent Development

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Merck Sharp & Dohme

    • 11.8.1 Merck Sharp & Dohme Company Profile and Recent Development

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Sun Pharmaceutical Industries

    • 11.9.1 Sun Pharmaceutical Industries Company Profile and Recent Development

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 Glaxo Smith Kline

    • 11.10.1 Glaxo Smith Kline Company Profile and Recent Development

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 Reddy Pharmaceuticals

    • 11.11.1 Reddy Pharmaceuticals Company Profile and Recent Development

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 Johnson & Johnson

    • 11.12.1 Johnson & Johnson Company Profile and Recent Development

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 84 Figures and 142 Tables)

  • Figure Product Picture

  • Figure Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate of Aspirin from 2014 to 2026

  • Figure Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate of Ibuprofen from 2014 to 2026

  • Figure Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate of Naproxen from 2014 to 2026

  • Figure Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate of Nabumetone from 2014 to 2026

  • Figure Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate of Back Pain Treatment from 2014 to 2026

  • Figure Global Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate of Osteoarthritis Treatment from 2014 to 2026

  • Figure Global Non-steroidal Anti-inflammatory Drugs Market Size and Growth Rate of Other from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Non-steroidal Anti-inflammatory Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Non-steroidal Anti-inflammatory Drugs Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Non-steroidal Anti-inflammatory Drugs

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Non-steroidal Anti-inflammatory Drugs by Different Types from 2014 to 2026

  • Table Consumption Share of Non-steroidal Anti-inflammatory Drugs by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Aspirin

  • Figure Market Size and Growth Rate of Ibuprofen

  • Figure Market Size and Growth Rate of Naproxen

  • Figure Market Size and Growth Rate of Nabumetone

  • Figure Market Size and Growth Rate of Others

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Non-steroidal Anti-inflammatory Drugs by Different End-Users from 2014 to 2026

  • Table Consumption Share of Non-steroidal Anti-inflammatory Drugs by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Back Pain Treatment

  • Figure Market Size and Growth Rate of Osteoarthritis Treatment

  • Figure Market Size and Growth Rate of Other

  • Table Global Non-steroidal Anti-inflammatory Drugs Production by Major Regions

  • Table Global Non-steroidal Anti-inflammatory Drugs Production Share by Major Regions

  • Figure Global Non-steroidal Anti-inflammatory Drugs Production Share by Major Regions in 2014

  • Figure Global Non-steroidal Anti-inflammatory Drugs Production Share by Major Regions in 2018

  • Figure Global Non-steroidal Anti-inflammatory Drugs Production Share by Major Regions in 2026

  • Table Global Non-steroidal Anti-inflammatory Drugs Consumption by Major Regions

  • Table Global Non-steroidal Anti-inflammatory Drugs Consumption Share by Major Regions

  • Figure Global Non-steroidal Anti-inflammatory Drugs Consumption Share by Major Regions in 2014

  • Figure Global Non-steroidal Anti-inflammatory Drugs Consumption Share by Major Regions in 2018

  • Figure Global Non-steroidal Anti-inflammatory Drugs Consumption Share by Major Regions in 2026

  • Table North America Non-steroidal Anti-inflammatory Drugs Production, Import, Consumption and Export Analysis

  • Table Europe Non-steroidal Anti-inflammatory Drugs Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Non-steroidal Anti-inflammatory Drugs Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Non-steroidal Anti-inflammatory Drugs market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Non-steroidal Anti-inflammatory Drugs market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Non-steroidal Anti-inflammatory Drugs market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Non-steroidal Anti-inflammatory Drugs market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Non-steroidal Anti-inflammatory Drugs Consumption by Types from 2014 to 2026

  • Table North America Non-steroidal Anti-inflammatory Drugs Consumption Share by Types from 2014 to 2026

  • Figure North America Non-steroidal Anti-inflammatory Drugs Consumption Share by Types in 2014

  • Figure North America Non-steroidal Anti-inflammatory Drugs Consumption Share by Types in 2018

  • Figure North America Non-steroidal Anti-inflammatory Drugs Consumption Share by Types in 2026

  • Table North America Non-steroidal Anti-inflammatory Drugs Consumption by End-Users from 2014 to 2026

  • Table North America Non-steroidal Anti-inflammatory Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure North America Non-steroidal Anti-inflammatory Drugs Consumption Share by End-Users in 2014

  • Figure North America Non-steroidal Anti-inflammatory Drugs Consumption Share by End-Users in 2018

  • Figure North America Non-steroidal Anti-inflammatory Drugs Consumption Share by End-Users in 2026

  • Table North America Non-steroidal Anti-inflammatory Drugs Consumption by Major Countries from 2014 to 2026

  • Table North America Non-steroidal Anti-inflammatory Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Non-steroidal Anti-inflammatory Drugs Consumption Share by Major Countries in 2014

  • Figure North America Non-steroidal Anti-inflammatory Drugs Consumption Share by Major Countries in 2018

  • Figure North America Non-steroidal Anti-inflammatory Drugs Consumption Share by Major Countries in 2026

  • Figure United States Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Non-steroidal Anti-inflammatory Drugs Consumption by Types from 2014 to 2026

  • Table Europe Non-steroidal Anti-inflammatory Drugs Consumption Share by Types from 2014 to 2026

  • Figure Europe Non-steroidal Anti-inflammatory Drugs Consumption Share by Types in 2014

  • Figure Europe Non-steroidal Anti-inflammatory Drugs Consumption Share by Types in 2018

  • Figure Europe Non-steroidal Anti-inflammatory Drugs Consumption Share by Types in 2026

  • Table Europe Non-steroidal Anti-inflammatory Drugs Consumption by End-Users from 2014 to 2026

  • Table Europe Non-steroidal Anti-inflammatory Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Non-steroidal Anti-inflammatory Drugs Consumption Share by End-Users in 2014

  • Figure Europe Non-steroidal Anti-inflammatory Drugs Consumption Share by End-Users in 2018

  • Figure Europe Non-steroidal Anti-inflammatory Drugs Consumption Share by End-Users in 2026

  • Table Europe Non-steroidal Anti-inflammatory Drugs Consumption by Major Countries from 2014 to 2026

  • Table Europe Non-steroidal Anti-inflammatory Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Non-steroidal Anti-inflammatory Drugs Consumption Share by Major Countries in 2014

  • Figure Europe Non-steroidal Anti-inflammatory Drugs Consumption Share by Major Countries in 2018

  • Figure Europe Non-steroidal Anti-inflammatory Drugs Consumption Share by Major Countries in 2026

  • Figure Germany Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure France Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Non-steroidal Anti-inflammatory Drugs Consumption by Types from 2014 to 2026

  • Table Asia Pacific Non-steroidal Anti-inflammatory Drugs Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Non-steroidal Anti-inflammatory Drugs Consumption Share by Types in 2014

  • Figure Asia Pacific Non-steroidal Anti-inflammatory Drugs Consumption Share by Types in 2018

  • Figure Asia Pacific Non-steroidal Anti-inflammatory Drugs Consumption Share by Types in 2026

  • Table Asia Pacific Non-steroidal Anti-inflammatory Drugs Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Non-steroidal Anti-inflammatory Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Non-steroidal Anti-inflammatory Drugs Consumption Share by End-Users in 2014

  • Figure Asia Pacific Non-steroidal Anti-inflammatory Drugs Consumption Share by End-Users in 2018

  • Figure Asia Pacific Non-steroidal Anti-inflammatory Drugs Consumption Share by End-Users in 2026

  • Table Asia Pacific Non-steroidal Anti-inflammatory Drugs Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Non-steroidal Anti-inflammatory Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Non-steroidal Anti-inflammatory Drugs Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Non-steroidal Anti-inflammatory Drugs Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Non-steroidal Anti-inflammatory Drugs Consumption Share by Major Countries in 2026

  • Figure China Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandNon-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure India Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Consumption Share by Major Countries in 2026

  • Figure GCC Countries Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Non-steroidal Anti-inflammatory Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Bayer

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

  • Figure Sales and Growth Rate Analysis of Bayer

  • Figure Revenue and Market Share Analysis of Bayer

  • Table Product and Service Introduction of Bayer

  • Table Company Profile and Development Status of Novacap

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novacap

  • Figure Sales and Growth Rate Analysis of Novacap

  • Figure Revenue and Market Share Analysis of Novacap

  • Table Product and Service Introduction of Novacap

  • Table Company Profile and Development Status of Abbott

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott

  • Figure Sales and Growth Rate Analysis of Abbott

  • Figure Revenue and Market Share Analysis of Abbott

  • Table Product and Service Introduction of Abbott

  • Table Company Profile and Development Status of Pfizer

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

  • Figure Sales and Growth Rate Analysis of Pfizer

  • Figure Revenue and Market Share Analysis of Pfizer

  • Table Product and Service Introduction of Pfizer

  • Table Company Profile and Development Status of Geri-Care Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Geri-Care Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of Geri-Care Pharmaceuticals

  • Figure Revenue and Market Share Analysis of Geri-Care Pharmaceuticals

  • Table Product and Service Introduction of Geri-Care Pharmaceuticals

  • Table Company Profile and Development Status of Perrigo Company

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Perrigo Company

  • Figure Sales and Growth Rate Analysis of Perrigo Company

  • Figure Revenue and Market Share Analysis of Perrigo Company

  • Table Product and Service Introduction of Perrigo Company

  • Table Company Profile and Development Status of Kopran

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kopran

  • Figure Sales and Growth Rate Analysis of Kopran

  • Figure Revenue and Market Share Analysis of Kopran

  • Table Product and Service Introduction of Kopran

  • Table Company Profile and Development Status of Merck Sharp & Dohme

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck Sharp & Dohme

  • Figure Sales and Growth Rate Analysis of Merck Sharp & Dohme

  • Figure Revenue and Market Share Analysis of Merck Sharp & Dohme

  • Table Product and Service Introduction of Merck Sharp & Dohme

  • Table Company Profile and Development Status of Sun Pharmaceutical Industries

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical Industries

  • Figure Sales and Growth Rate Analysis of Sun Pharmaceutical Industries

  • Figure Revenue and Market Share Analysis of Sun Pharmaceutical Industries

  • Table Product and Service Introduction of Sun Pharmaceutical Industries

  • Table Company Profile and Development Status of Glaxo Smith Kline

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glaxo Smith Kline

  • Figure Sales and Growth Rate Analysis of Glaxo Smith Kline

  • Figure Revenue and Market Share Analysis of Glaxo Smith Kline

  • Table Product and Service Introduction of Glaxo Smith Kline

  • Table Company Profile and Development Status of Reddy Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Reddy Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of Reddy Pharmaceuticals

  • Figure Revenue and Market Share Analysis of Reddy Pharmaceuticals

  • Table Product and Service Introduction of Reddy Pharmaceuticals

  • Table Company Profile and Development Status of Johnson & Johnson

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

  • Figure Sales and Growth Rate Analysis of Johnson & Johnson

  • Figure Revenue and Market Share Analysis of Johnson & Johnson

  • Table Product and Service Introduction of Johnson & Johnson


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top